faid2013.france-science.org
2013 FAID - About the Organizers
http://www.faid2013.france-science.org/about_inserm.html
Founded in 2000, InsermTransfert SA is the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), dedicated to technology transfer (from invention disclosure to industrial partnership). Inserm Transfert also manages European and International research projects, supports large scale projects in epidemiology and public health. A 397m life sciences seed investment company. About Inserm Transfert Initiative. Photo credits from top to bottom:.
bioaxial.com
Home
http://www.bioaxial.com/index.php
Overcoming the Diffraction Limit. Add CODIM super-resolution module to your confocal microscope. No specific sample preparation vs confocal. Low phototoxicity and bleaching. 80 µm penetration depth. One button super-resolution zoom. Fully integrated in NIS-Elements. Simultaneous confocal and super-resolved images. CODIM images 80 µm-deep brain tissues in super-resolution. CODIM reveals impact of cannabinoids on neuronal growth cones. CODIM resolution vs confocal on neuronal growth cones.
inserm-transfert.fr
R&D, Licensing - Inserm Transfert
http://inserm-transfert.fr/en/partnering/rad.html
Maturation, Protecting and IP. Partnering: R&D, Public health. Partnering: R&D, Public health. R&D contracts (MAT, CDA,.). Inserm Transfert's primary objective in licensing technology or signing R&D partnerships is to maximize the likelihood that technologies and know-how will reach the market in a timely fashion. We place great value on building strong public-private partnerships between biopharmaceutical companies and academic research teams/centres to accomplish this strategic goal. How do we do it?
inserm-transfert.fr
Spin-offs - Inserm Transfert
http://inserm-transfert.fr/en/achievements/spinoffs.html
Maturation, Protecting and IP. Partnering: R&D, Public health. Some remarkable spin-offs backed by Inserm's technology. More than 120 start-ups companies have been created over the past 35 years. Cancer and inflammatory diseases. Biomarkers for inflammatory chronic diseases. Cancer and chronic infectious diseases. All therapy for chronic inflammatory diseases. Maturation, Protecting and IP. Partnering: R&D, Public health. Paris Biopark - 7 rue Watt - 75013 PARIS. 33 (0)1 55 03 01 00. 33 (0)1 55 03 01 60.
inserm-transfert.fr
Events - Inserm Transfert
http://inserm-transfert.fr/en/events.html
Maturation, Protecting and IP. Partnering: R&D, Public health. Page 1 of 2. July 4-5th - The Corum Conference Centre, Montpellier - France. The 4th Antibody Industrial Symposium 2016 (AIS2016). Meeting offers an ideal conference for scientists, industries, physicians and policy makers to exchange about Therapeutic Antibodies. The Scientific committee has set-up an exciting program focusing on the following theme: Current and Next Generation Antibody Formats. The topics covered during this meeting are:.
inserm-transfert.fr
Missions - Inserm Transfert
http://inserm-transfert.fr/index.php/overview/missions
Maturation, Protecting and IP. Partnering: R&D, Public health. Inserm Transfert is the Inserm subsidiary dedicated to knowledge transfer. We focus on adding value and minimizing risk for innovative projects at pre-industrial stage, bridging discovery and clinical research. We put emphasis on identifying high-potential projects, implementing appropriate proof of concept and IP strategies, and setting up win-win/mutually beneficial industrial partnerships. We strive to prevent diseases and cure patients.
inserm-transfert.fr
Downloads - Inserm Transfert
http://www.inserm-transfert.fr/index.php/downloads
Maturation, Protecting and IP. Partnering: R&D, Public health. European and international affairs. Animal models and Cell lines. Https:/ migratech.inserm-transfert.fr. Https:/ migratech.inserm-transfert.fr. Maturation, Protecting and IP. Partnering: R&D, Public health. Paris Biopark - 7 rue Watt - 75013 PARIS. 33 (0)1 55 03 01 00. 33 (0)1 55 03 01 60.
axilumrobotics.com
Investors of Axilum Robotics company - Axilum Robotics [EN]
http://www.axilumrobotics.com/en/investors.php
History & values. Accuracy & Repeatability. Axilum Robotics : Accueil. Article on Axilum Robotics TMS-Robot in CNRS News magazine of May 2016. Axilum Robotics announces the installation of a new robotic system for Transcranial Magnetic Stimulation in Canada. Axilum Robotics and Rogue Resolutions announce the installation of a new robotic system for Transcranial Magnetic Stimulation in Spain. Scientific meeting of STEP in Ghent. 2011-2016 Axilum Robotics Legal notice. General Terms of Sale.
tremplin-entreprises.senat.fr
Partenaires Grand Prix | Tremplin Entreprises 2016
http://www.tremplin-entreprises.senat.fr/partenaires/partenaires-grand-prix
Co-organisé par le Sénat et l’ESSEC, Tremplin Entreprises est un concours national pour les entreprises innovantes. Partenaires Prix coup de coeur. Les 4 Grand Prix et les trophées seront remis, suite à une décision collégiale du comité de sélection, au projet le plus prometteur de chaque catégorie. Remettra le prix de la catégorie Energies, matériaux et composants . Inserm Transfert et Inserm Transfert Initiative remettront le prix de la catégorie Sciences de la Vie . Inserm Transfert, la filiale privée...
inserm-transfert.fr
R&D Alliances - Inserm Transfert
http://inserm-transfert.fr/en/rad-alliances.html
Maturation, Protecting and IP. Partnering: R&D, Public health. Inserm Transfert's primary objective in licensing technology or signing R&D partnerships is. To maximize the likelihood that technologies and know-how will reach the market in a timely fashion. We place great value on building strong public-private partnerships between biopharmaceutical companies and academic research teams/centres. To accomplish this strategic goal. Inserm / C.Minghelli. How do we do it? Maturation, Protecting and IP.